Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Sodium Compounds”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMedDate not supplied

Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.

The effects of a series of phenolic compounds were compared to the effects of sodium salicylate (2-hydroxybenzoate) on the growth, cell cycle and apoptotic effects in wild-type (WT) and deoxyadenosine-resistant (Y8) L1210 leukemia cells. These compounds included: salicylaldehyde, salicylaldoxime, salicylhydroxamic acid, salicylamide, 5-aminosalicylate and 5-sulfosalicylate. The IC50 values for inhibition of tumor cell growth ranged from 40 microM for salicylaldhyde to greater than 4 mM for 5-sulfosalicylate. There appeared to be an excellent correlation between the IC50 value for a compound and the ratio of octanol/aqueous distribution. Salicylamide caused a G2/M block in both the WT and Y8 L1210 cells, while salicylalehyde caused a G0/G1 block in both the WT and Y8 cells. Salicylamide and salicylaldoxime caused a much greater apoptotic effect in the Y8 cells than in the parental WT L210 cells. These data suggest that salicylaldehyde and salicylaldoxime, the most active compounds in this series, may provide the lead chemicals from which other more active drugs can be synthesized.

Aldehydes↗
PubMed2004

[A new method of oxygen delivery to preventing and relieving the anoxia injury--an experimental study and clinical application of hyperoxygen compound sodium chloride solution in treatment of burn shock].

OBJECTIVE: To evaluate the clinic effects and prognosis of hyperoxygen compound sodium chloride solution (HCSCS) in treatment of burn shock. METHODS: (1) Severe burned patients with 50% - 69% TBSA were enrolled and randomly divided into 2 groups, treated by HCSCS and CSCS respectively. Indices such as PaO(2), Hb, Hct and complication were observed. (2) Severe burned patients with more than 70% TBSA were enrolled and indices above and lactate were investigated as well. RESULTS: (1) The cases treated with HCSCS showed relatively stabilization during shock stage, little complication, less liquor volume and remarkable higher oxygen pressure. (2) Severe burned patients with more than 70% TBSA had high level of PaO(2) and normal lactate and less complication. CONCLUSION: The early application of HCSCS is a relatively effective method in treatment of burn shock and favourable prognosis.

Adult↗
PubMed2001

Effectiveness of the sulfur(IV) compound, sodium bisulfite, in reducing chlorine, chlorine dioxide, and chlorite toxicity to Daphnia magna in well water and pond water.

Flow-through toxicity tests were conducted with Daphnia magna to determine the residual toxicity of chlorine, chlorine dioxide, and chlorite after treatment with the sulfur(IV) compound sodium bisulfite. Daphnids were exposed separately to 0.5-mg/L concentrations of each of the three compounds without the addition of sodium bisulfite, with a low stoichiometric dose of sodium bisulfite, and with a high stoichiometric dose of sodium bisulfite. Tests were performed in well water with a low total organic carbon (TOC) content and pond water with a high TOC content. Analysis of results indicated that sodium bisulfite did not eliminate the toxicity of chlorine dioxide or chlorite to D. magna. Total residual oxidant (TRO) concentrations were reduced and survival times were extended, but acute toxicity persisted even with a S(IV) concentration 10.0 times the stoichiometric ratio of oxidant. Mortality occurred in chlorine dioxide treatments in which no TRO was detected, indicating that standard analytical (amperometric) techniques may be inadequate to detect toxicity. Sodium bisulfite did succeed in eliminating chlorine toxicity except in pond water receiving a low (3.0x) sodium bisulfite dose. Oxidant reactions with organic substrates may have produced chlorinated residuals that were resistant to S(IV) dechlorination.

Animals↗
PubMed2026

Physicochemical effects of bicarbonate-buffered solution versus compound sodium lactate during major abdominal surgery: A randomized, open-label, non-inferiority trial.

INTRODUCTION: Bicarbonate-buffered crystalloids avoid exogenous lactate and have physicochemical properties distinct from compound sodium lactate (CSL), but direct comparative evidence during major abdominal surgery remains limited. METHODS: This single-center, open-label, randomized non-inferiority trial enrolled high-risk adults undergoing elective major abdominal surgery. Participants received bicarbonate-buffered solution or CSL as the allocated intraoperative crystalloid. The primary estimand was the arithmetic mean difference in standard base excess (SBE) at skin closure (bicarbonate-buffered solution minus CSL). The non-inferiority margin was -1.5 mEq/L. The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry (ACTRN12619001228178). RESULTS: Fifty participants were randomized (25 per group) and received their allocated intervention. End-of-surgery arterial blood gas data were missing for two CSL participants. In the intention-to-treat analysis using multiple imputation, the estimated mean difference in end-of-surgery SBE was -0.42 mEq/L (95% confidence interval [CI], -1.92 to 1.09 mEq/L). The complete-case per-protocol estimate was -0.48 mEq/L (95% CI, -2.02 to 1.06 mEq/L). In both analyses, the lower CI bound was below the prespecified non-inferiority margin; non-inferiority was not established. Secondary outcomes were exploratory; observed end-of-surgery lactate was lower with bicarbonate-buffered solution (median 0.9 vs 1.2 mmol/L; unadjusted P = 0.031), without a corresponding difference in SBE or pH. CONCLUSIONS: In this small trial of hemodynamically stable adults undergoing elective major abdominal surgery, the primary non-inferiority result was inconclusive. The data did not establish interchangeability, equivalence, superiority, or inferiority of the two fluids. As the trial was powered for a physiologic endpoint, no comparative inference can be made about organ dysfunction, postoperative complications, recovery, or mortality. Larger trials with standardized co-interventions and patient-important outcomes are required before routine substitution for CSL can be recommended.

Humans↗
PubMed2005

Sodium compounds of the benzophenone dianion (diphenyloxidomethanide).

The benzophenone dianion [diphenyloxidomethanide, (Ph(2)CO)(2-)], which occurs in the well known deeply violet sodium/benzophenone tetrahydrofuran solutions, was crystallised with sodium cations in form of the two polymeric chain compounds [Na(2)(Ph(2)CO)(tetraglyme)](infinity) and [Na(2)(Ph(2)CO)(thf)(2)](infinity). It was found to aggregate with its conjugated acid, the alcoholate (Ph(2)CHO)(-), around a central unit of sodium hydroxide, resulting in the mixed cage compound [Na(13)(Ph(2)CO)(4)(Ph(2)CHO)(4)(OH)(mtbe)(4)].mtbe. The structural parameters of the benzophenone dianion indicate that a considerable amount of its negative charge is located within the phenyl rings, rather than on the formally anionic benzylic carbon atom. The topological analysis of the electron density of the monomeric model structure [Na(2)(Ph(2)CO)] reveals an even positive charge for this particular atom, hence (Ph(2)CO)(2-) is, despite its usual representation, not a vicinal dianion.

Journal Article↗
PubMed1995

Synthesis and anticonvulsant activity of enaminones. 3. Investigations on 4'-, 3'-, and 2'-substituted and polysubstituted anilino compounds, sodium channel binding studies, and toxicity evaluations.

In a continuing evaluation of the aniline-substituted enaminones, the synthesis of additional para-substituted analogs has been made in an attempt to further quantify the electronic (sigma) and lipophilic (pi) requirements for anticonvulsant activity in this series. In addition, meta- and ortho-substituted and polysubstituted compounds have been synthesized and evaluated for anticonvulsant activity. In the para-substituted series, 4-cyano analogs (32 and 33) (+ sigma, - pi), which were highly active via intraperitoneal (ip) injection in mice, were inactive on oral (po) administration in rats. The para-substituted trifluoromethoxy (+ sigma, + pi) analog (8) had significant potency by both routes. Meta substitution limited the activity due to steric factors. Bromo and iodo substituents produced active para-substituted analogs (5 and 17) but were inactive when substituted in the meta position (37 and 41, respectively). Ortho substitution provided no clear relationship due to nonparametric deviations. Neither 1, the prototype enaminone, nor 2, the putative metabolite, produced significant nephrotoxicity or hepatotoxicity. Sodium channel binding of 1 and 8 indicated that 8 displayed relatively potent sodium channel binding but 1 showed weaker effects with IC50 values of 489 and 170 microM respectively against [3H]batrachotoxinin A 20 alpha-benzoate ([3H]BTX-B).

Animals↗
PubMed1997

Comparison of oral sodium compounds for the correction of acidosis.

Three Na compounds were tested to determine which was best able to treat metabolic acidosis in dairy cows. Metabolic acidosis was induced in test cows by feeding a diet that was high in anions for 7 d before the administration of treatment on d 8. The orally administered treatments were equivalent amounts of Na in the form of NaCl (208.6 g), NaHCO3 (300 g), or Na propionate (343 g). The initiation of oral treatment was designated as time 0, and blood samples were taken 15 min before treatment, immediately before treatment, and 15, 30, 45, 60, 90, 120, 180, 240, 300, and 360 min after treatment. Before treatment, all cows were in a state of metabolic acidosis as was evidenced by low blood pH, low HCO3 concentrations, and high plasma Cl concentrations. After treatment, blood pH and HCO3 were markedly higher for cows receiving NaHCO3 and Na propionate but not for cows receiving NaCl. We concluded that orally administered NaHCO3 and Na propionate were equally effective in correcting the acid-base balance of blood, as was predicted by the strong ion difference theory of acid-base physiology. Sodium propionate may be considered a more effective treatment of metabolic acidosis in diseases such as ketosis because the added propionate can serve as a source of glucose for the cow.

Acidosis↗
PubMed1986

Compound sodium lactate (Hartmann's) solution. Caution: risk of clotting.

We have observed blood clotting in blood administration sets where Hartmann's solution (Travenol) has preceded blood transfusion. This is due to calcium ions (Ca++) contained in the Hartmann's solution and is more likely to occur at 37 degrees C. We suggest that this potential hazard be more widely realised and that the practice cease.

Blood Coagulation↗
PubMed1991

Characteristics of histamine secretion from mast cells stimulated with sodium orthovanadate and other vanadium compounds.

Sodium orthovanadate was found to be an effective histamine liberator from serosal mast cells of the rat and mouse. The release process was slow, non-cytotoxic and strongly dependent on pH and extracellular calcium. The effect was highly tissue and species specific and human basophil leucocytes, human lung mast cells and tissue mast cells of the rat and guinea pig were only weakly responsive or essentially unreactive. Other oxyanions of vanadium with the metal in the (+V) oxidation state also evoked histamine release from rat peritoneal mast cells but neither vanadyl sulphate (+IV oxidation state) nor the analogous orthophosphate anion were effective secretagogues. On the basis of these results, the possible mechanism of action of vanadate is discussed.

Animals↗
PubMed1976

Solution properties of sulfobromophthalein sodium (BSP) compounds alone and in association with sodium taurocholate (TC).

A series of in vitro studies have been performed utilizing the techniques of ultracentrifugation, freezing point depression, vapor pressure osmometry, and spectrophotometry, to study the colloid-chemical characteristics of various sulfobromophthalein sodium (BSP) compounds in aqueous solution and to evaluate the possibility of a direct physicochemical interaction between BSP and taurocholate (TC). The results of these studies indicate that: (1) BSP compounds self-associate in aqueous solution to form polymolecular aggregates. These aggregates are larger with conjugated BSP, where the aggregation number appears to increase with the concentration of BSP, compared with the more polar glutathione conjugate of BSP; (2) There is a marked physicochemical interaction between unconjugated BSP and TC and a much smaller effect between the bile salt and conjugated BSP. This interaction was minor between BSP and glycodeoxycholate or taurodehydrocholate but was reproduced fully by glycocholate. Such an interaction between BSP and TC may have physiologic importance and may help to explain the previously noted facilitated excretion of BSP observed after infusion of TC in experimental animals.

Journal Article↗
PubMed1980

Gas-liquid chromatographic determination of sodium fluoroacetate (Compound 1080).

An analytical method is described for the determination of Compound 1080 (sodium fluoroacetate) residues in 1--10 g tissue. Sample extracts of tissues are cleaned up with silica gel, and Compound 1080 (as fluoroacetic acid) is separated by a micro-distillation procedure. The fluoroacetic acid in the distillate is derivatized with pentafluorobenzyl bromide to form pentafluorobenzyl fluoroacetate which is measured by electron capture gas-liquid chromatography. Recoveries of sodium fluoroacetate from fortified tissue samples averaged about 25%. Despite the limited recoveries, results were quite reproducible, and levels as low at 2 ppm were determined in fortified 1 g samples, and 0.2 ppm in 10 g samples. The method is relatively simple and has been used routinely in our laboratory for the analysis of various types of samples such as grain, and tissues from birds, rodents, and larger animals.

Animals↗
PubMed1989

Detection of the pesticide compound 1080 (sodium monofluoroacetate) using fluorine-19 nuclear magnetic resonance spectroscopy.

Fluorine-19 nuclear magnetic resonance (19F NMR) spectroscopic measurements were used to determine the chemical nature and amounts of organofluorine in dosed meat baits. Earlier work implied that sodium monofluoroacetate (compound 1080) in meat baits was broken down into other organofluorine compounds such as fluorocitrate. No chemical evidence was found for such compounds. Only monofluoroacetate was detected in the prepared 1080 bait samples. Once the baits have aged, aqueous extraction fails to recover all the added 1080. Analysis using 19F NMR confirmed that the 1080 present in the aqueous extracts of the bait is recovered by Kramer's liquid chromatography method. It was shown here that the aqueous extracts do not recover all the 1080 in the meat bait.

Animals↗